Sign In
Buy PFE
$26.04
+0.350 (+1.36%)
At Close: Jun 05, 2026
Pfizer is looking beyond the COVID-19 market, aiming to be the 'partner of choice for biotech'
12:46pm, Friday, 06'th May 2022 MarketWatch
The company is already laying the groundwork for what it will look like when revenue from its COVID-19 franchise begins to wane.
Mega Caps Struggle, Becky Quick on Berkshire-Hathaway's Future
10:31am, Friday, 06'th May 2022 The Motley Fool
The biggest companies in the U.S. markets couldn't stop April being the worst month for the stock market in years.
Pfizer Is Poised to Shatter These 2 Records in 2022
09:55am, Thursday, 05'th May 2022 The Motley Fool
The big drugmaker should be in store for a banner year on a couple of fronts.
4 Analysts Have This to Say About Pfizer
03:04pm, Wednesday, 04'th May 2022 Benzinga
Within the last quarter, Pfizer (NYSE:PFE) has observed the following analyst ratings:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
0
1
3
0
0
Last 30D
0
1
1
0
Should You Invest in the iShares U.S. Healthcare ETF (IYH)?
10:20am, Wednesday, 04'th May 2022 Zacks Investment Research
Sector ETF report for IYH
Why Pfizer Stock Climbed Today
10:47pm, Tuesday, 03'rd May 2022 The Motley Fool
Demand for COVID-19 vaccines and treatments is fueling the pharma giant's profit growth.
Why Moderna Trounced the Market on Tuesday
10:36pm, Tuesday, 03'rd May 2022 The Motley Fool
Strong coronavirus vaccine sales reported by a peer presage a fine first quarter for the biotech.
U.S. stock benchmarks end higher after choppy trade on eve of expected half-point Fed interest rate hike
08:27pm, Tuesday, 03'rd May 2022 MarketWatch
U.S. stock indexes end higher Tuesday after choppy trade on the eve of what's expected to be the most aggressive Federal Reserve tightening in two decades.
Omicron caused spike in deaths in vaccinated people, analysis finds, though unvaccinated remain most at risk
06:18pm, Tuesday, 03'rd May 2022 MarketWatch
The omicron variant of the coronavirus that causes COVID-19 that has swept across the U.S. since late last year has taken a grimmer toll than earlier variants, including in people who were vaccinated
Why Kymera Therapeutics Stock Is Getting Hammered Today
05:09pm, Tuesday, 03'rd May 2022 The Motley Fool
The biotech upset investors today with disappointing news for its lead program.
BioNTech (BNTX) to Report Q1 Earnings: What's in the Cards?
03:22pm, Tuesday, 03'rd May 2022 Zacks Investment Research
On BioNTech's (BNTX) first-quarter earnings call, investors' focus is expected to be on the sales performance of its COVID-19 vaccine, Comirnaty, developed in partnership with Pfizer.
Pfizer lowers earnings guidance despite a solid Q1
03:18pm, Tuesday, 03'rd May 2022 Invezz
Shares of Pfizer Inc (NYSE: PFE) are slightly up this morning after the pharmaceutical giant reported market-beating results for its fiscal Q1 on strong sales of its COVID treatments. Pfizer Q1 financ
3 Flaws in Pfizer's Otherwise Stellar Q1 Results
02:56pm, Tuesday, 03'rd May 2022 The Motley Fool
The negatives in Pfizer's Q1 update shouldn't worry investors.
Pfizer (PFE) Q1 Earnings & Sales Miss Estimates, Stock Down
02:42pm, Tuesday, 03'rd May 2022 Zacks Investment Research
Pfizer (PFE) misses estimates for Q1 earnings and sales. It did not raise its sales guidance for 2022. Stock declines.
Fed's Crucial FOMC Meeting in Focus
02:37pm, Tuesday, 03'rd May 2022 Zacks Investment Research
Fed's Crucial FOMC Meeting in Focus.
